Atomera Inc (ATOM) Stock Analysis and Metrics

Sector: Technology Industry: Semiconductor Equipment & Materials CIK: 0001420520

Market Cap 110.42 Mn

P/E -5.51

P/S 1,698.79

Div. Yield 0.00

Add ratio to table...

About

Atomera Inc., often recognized by its stock symbol ATOM, operates in the semiconductor industry. This company is renowned for its innovative development, commercialization, and licensing of proprietary processes and technologies, with a particular focus on its lead technology, Mears Silicon Technology (MST). MST is a thin film of reengineered silicon that can be utilized as a transistor channel enhancement for CMOS-type transistors, the most widely used transistor type in the semiconductor industry. Atomera's primary business activities revolve...

Atomera Inc., often recognized by its stock symbol ATOM, operates in the semiconductor industry. This company is renowned for its innovative development, commercialization, and licensing of proprietary processes and technologies, with a particular focus on its lead technology, Mears Silicon Technology (MST). MST is a thin film of reengineered silicon that can be utilized as a transistor channel enhancement for CMOS-type transistors, the most widely used transistor type in the semiconductor industry.

Atomera's primary business activities revolve around the development and licensing of its MST technology. The company operates in various countries, collaborating with a wide array of industry players, including foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. Atomera's revenue is generated through a three-stage licensing approach, which includes an integration license, a manufacturing license, and a distribution license. The upfront license fee increases at each stage, and royalties are paid based on the number and sales price of MST-enabled products sold to customers.

Atomera's MST technology holds significant potential to address key engineering challenges in the semiconductor industry. These include enhancing drive current, reducing gate leakage, and reducing variability. The technology can be applied to a broad spectrum of devices, encompassing microprocessors, logic products, analog, RF, and mixed-signal devices, as well as DRAM, SRAM, and other memory integrated circuits.

Atomera competes with IDMs, OEMs, foundries, fabless manufacturers of semiconductors, and semiconductor IP licensing companies. However, the company believes that its MST technology has the potential to be a low-cost, additive technology that would not face significant direct competition from other technologies. Atomera's competitive advantage lies in its ability to provide a low-cost improvement to the standard fabrication process, making it an attractive option for the industry.

Atomera's customers and partners include STMicroelectronics, which has entered into a full commercial license agreement with Atomera. STMicroelectronics has performed extensive evaluations of Atomera's MST technology and has granted them an integration license. Additionally, Atomera has developed partnerships with OEMs, such as Applied Materials, to ensure that MST can be reliably and predictably deposited using their manufacturing tools.

Atomera's primary product is its MST technology, a proprietary and patent-protected performance enhancement technology. The company's research and development efforts are primarily focused on enabling existing and prospective customers to integrate MST into their manufacturing processes and enabling them to commercialize MST-enabled semiconductor products. Atomera also dedicates research and development resources to evolving and expanding its technology to address new process technologies in the semiconductor industry roadmap.

Atomera's intellectual property rights are a crucial aspect of its business operations. The company relies primarily on a combination of patent laws, trade secret laws, confidentiality procedures, and contractual provisions to protect its proprietary technology. As of December 31, 2023, Atomera has been granted 216 patents in total, with 103 patents in the U.S. and 113 abroad, and has 106 pending patent applications, with 35 in the U.S. and 71 abroad.

Investment thesis

Bull case

Atomera’s Gate All Around results demonstrate a clear technical breakthrough that can be directly applied to 2 nanometer and below 2 nanometer transistors. The company obtained silicon level data confirming both deposition capability and superior diffusion blocking in the nanosheet structure, which addresses a core yield issue. These results were achieved using standard tools and gases, making adoption less disruptive for foundries. If the technology is accepted by the industry’s four major GAA customers, the upside could extend far beyond the current wafer based licensing model.
A strategic alliance with a leading equipment OEM signals industry confidence and a clear path to volume production. The OEM’s established relationships with the four GAA customers could accelerate commercial integration of Atomera’s material. By leveraging the OEM’s tool platforms, the company can avoid costly re‑tooling and benefit from economies of scale. The partnership also provides a credible validation framework that investors can use to assess the likelihood of licensing deals.
Atomera is actively validating two wafer based DRAM solutions that target next generation node architectures. The preliminary test results appear promising, and the company is in joint development discussions that could lead to a production license. As DRAM vendors maintain significant R&D budgets during the current memory cycle, the opportunity for early adoption is substantial. Successful commercialization would provide a recurring revenue stream that complements the GAA focus.
The company’s RF SOI offering is designed to improve performance for switches and low noise amplifiers, two key components in wireless infrastructure. Because the solution can be delivered on blank wafers, customers can incorporate it early in the manufacturing flow, reducing integration risk. In addition, the GaN on silicon platform has attracted a commercial customer who is already running wafers with Atomera’s material. This early entry positions the firm ahead of competitors that are still confined to laboratory demonstrations.
Securing a commercial customer for GaN on silicon validates the technology’s manufacturability outside the lab. The customer’s ability to grow its own wafers and produce devices means that Atomera can focus on the material deposition step, which is a repeatable and scalable service. This arrangement also opens the door to further collaborations in power and RF applications, where GaN offers significant efficiency gains. The early commercial foothold reduces the sales cycle time relative to other material startups.

Atomera’s Gate All Around results demonstrate a clear technical breakthrough that can be directly applied to 2 nanometer and below 2 nanometer transistors. The company obtained silicon level data confirming both deposition capability and superior diffusion blocking in the nanosheet structure, which addresses a core yield issue. These results were achieved using standard tools and gases, making adoption less disruptive for foundries. If the technology is accepted by the industry’s four major GAA customers, the upside could extend far beyond the current wafer based licensing model.
A strategic alliance with a leading equipment OEM signals industry confidence and a clear path to volume production. The OEM’s established relationships with the four GAA customers could accelerate commercial integration of Atomera’s material. By leveraging the OEM’s tool platforms, the company can avoid costly re‑tooling and benefit from economies of scale. The partnership also provides a credible validation framework that investors can use to assess the likelihood of licensing deals.
Atomera is actively validating two wafer based DRAM solutions that target next generation node architectures. The preliminary test results appear promising, and the company is in joint development discussions that could lead to a production license. As DRAM vendors maintain significant R&D budgets during the current memory cycle, the opportunity for early adoption is substantial. Successful commercialization would provide a recurring revenue stream that complements the GAA focus.
The company’s RF SOI offering is designed to improve performance for switches and low noise amplifiers, two key components in wireless infrastructure. Because the solution can be delivered on blank wafers, customers can incorporate it early in the manufacturing flow, reducing integration risk. In addition, the GaN on silicon platform has attracted a commercial customer who is already running wafers with Atomera’s material. This early entry positions the firm ahead of competitors that are still confined to laboratory demonstrations.
Securing a commercial customer for GaN on silicon validates the technology’s manufacturability outside the lab. The customer’s ability to grow its own wafers and produce devices means that Atomera can focus on the material deposition step, which is a repeatable and scalable service. This arrangement also opens the door to further collaborations in power and RF applications, where GaN offers significant efficiency gains. The early commercial foothold reduces the sales cycle time relative to other material startups.

Bear case

Atomera reported only $65,000 in revenue for the full year, a figure that is essentially a token of activity rather than a sustainable income stream. The entire number is derived from a handful of NRE fees and licensing agreements, indicating that the company has not yet secured recurring customers. When compared to its peers, such a negligible top line exposes the business to extreme volatility. Investors may view this as a signal that the firm is still in a pre revenue phase, not a mature technology vendor.
Atomera’s commercial prospects are heavily concentrated in a narrow set of customers, many of whom are still in the experimental stage of their fabrication processes. Without a diversified customer base, a single partner’s decision to pivot or cancel a project could materially harm Atomera’s top line. Furthermore, the wafer run model places the firm at the mercy of foundry schedules and resource allocation, which are outside its control. This concentration risk makes the business model fragile.
Atomera’s sales model relies on customers sending wafers to the company for material deposition, followed by a 6 to 9 month period for the customers to complete fabrication and return results. This long lead time delays the company’s ability to recognize revenue and hampers cash flow management. The extended cycle also increases the risk that technical issues discovered later could nullify early positive results, further eroding customer confidence. Such delays are a classic bottleneck for wafer based service providers.
While the company claims to be in joint development discussions, no definitive licensing agreements have been announced. The lack of signed contracts means that revenue expectations remain speculative, and the company must still invest heavily in research and validation to prove the technology. If any of these negotiations stall or fall through, Atomera would be left with significant sunk costs and no immediate return. This uncertainty makes the company’s future earnings profile highly unpredictable.
Scaling from silicon level proof of concept to commercial production is a non trivial engineering challenge. Atomera’s technology requires precise control of dopant migration in structures that are only a few nanometers wide, and even minor deviations can cause yield loss. The company has only demonstrated success in limited lab environments and one partner’s fabrication line; broader adoption will depend on replicating these results across multiple fabs. Any shortfall in scaling will directly impact the company’s ability to monetize its core offering.

Atomera reported only $65,000 in revenue for the full year, a figure that is essentially a token of activity rather than a sustainable income stream. The entire number is derived from a handful of NRE fees and licensing agreements, indicating that the company has not yet secured recurring customers. When compared to its peers, such a negligible top line exposes the business to extreme volatility. Investors may view this as a signal that the firm is still in a pre revenue phase, not a mature technology vendor.
Atomera’s commercial prospects are heavily concentrated in a narrow set of customers, many of whom are still in the experimental stage of their fabrication processes. Without a diversified customer base, a single partner’s decision to pivot or cancel a project could materially harm Atomera’s top line. Furthermore, the wafer run model places the firm at the mercy of foundry schedules and resource allocation, which are outside its control. This concentration risk makes the business model fragile.
Atomera’s sales model relies on customers sending wafers to the company for material deposition, followed by a 6 to 9 month period for the customers to complete fabrication and return results. This long lead time delays the company’s ability to recognize revenue and hampers cash flow management. The extended cycle also increases the risk that technical issues discovered later could nullify early positive results, further eroding customer confidence. Such delays are a classic bottleneck for wafer based service providers.
While the company claims to be in joint development discussions, no definitive licensing agreements have been announced. The lack of signed contracts means that revenue expectations remain speculative, and the company must still invest heavily in research and validation to prove the technology. If any of these negotiations stall or fall through, Atomera would be left with significant sunk costs and no immediate return. This uncertainty makes the company’s future earnings profile highly unpredictable.
Scaling from silicon level proof of concept to commercial production is a non trivial engineering challenge. Atomera’s technology requires precise control of dopant migration in structures that are only a few nanometers wide, and even minor deviations can cause yield loss. The company has only demonstrated success in limited lab environments and one partner’s fabrication line; broader adoption will depend on replicating these results across multiple fabs. Any shortfall in scaling will directly impact the company’s ability to monetize its core offering.

Geographical Breakdown of Revenue (2025)

Award Type Breakdown of Revenue (2025)

Peer comparison

Companies in the Semiconductor Equipment & Materials

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	ASML	Asml Holding Nv	567.21 Bn	43.57	14.90	5.11 Bn
2	AMAT	Applied Materials Inc /De	256.30 Bn	32.95	9.08	6.55 Bn
3	LRCX	Lam Research Corp	251.91 Bn	40.81	12.25	4.48 Bn
4	KLAC	Kla Corp	181.90 Bn	40.04	14.27	-
5	TER	Teradyne, Inc	43.97 Bn	79.41	13.78	0.20 Bn
6	Q	Qnity Electronics, Inc.	22.46 Bn	31.15	4.76	4.03 Bn
7	ENTG	Entegris Inc	16.47 Bn	70.04	5.15	3.70 Bn
8	AMKR	Amkor Technology, Inc.	10.20 Bn	27.34	1.52	1.45 Bn

Research Tools

Atomera Inc (NASDAQ: ATOM)

About

Investment thesis

Bull case

Bear case

Geographical Breakdown of Revenue (2025)

Award Type Breakdown of Revenue (2025)

Peer comparison

Research Tools

Atomera Inc (NASDAQ: ATOM)

About

Investment thesis

Bull case

Bear case

Geographical Breakdown of Revenue (2025)

Award Type Breakdown of Revenue (2025)

Peer comparison

Create an account

Sign In

Reset Password